Zura Bio appoints Eric Hyllengren as CFO; Verender Badial steps down effective July 7, 2025

Zura Bio Ltd

Eric Hyllengren appointed CFO effective July 7, 2025; previously COO/CFO at Atara Biotherapeutics and 15 years at Amgen.
Verender Badial resigns as CFO, stays as non-executive employee through July 31, 2025 to assist transition.
Badial receives £178,294.92 cash severance, accelerated vesting for 186,561 options; 303,100 options forfeited.
Hyllengren gets $475,000 base salary, 40% target bonus, and option for 672,000 shares vesting over 4 years.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.